STOCK TITAN
  1. Home
  2. Sec-filings
  3. THTX
  4. [6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)

[6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock THTX logo
Theratechnologies Inc

NASDAQ:THTX

THTX Rankings

#7048 Ranked by Market Cap
N/A Ranked by Dividends

THTX Latest News

Jul 9, 2025
Theratechnologies Reports Financial Results for the Second Quarter 2025
Jul 3, 2025
Theratechnologies to Announce Second Quarter 2025 Financial Results
Jul 2, 2025
Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak
May 29, 2025
Theratechnologies Reports on its Annual Meeting of Shareholders
May 2, 2025
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV

THTX Latest SEC Filings

Jul 10, 2025
[6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)
Jul 9, 2025
[6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)
Jul 9, 2025
[6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)
Jul 9, 2025
[6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)
Jul 9, 2025
[6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)

THTX Stock Data

144.84M
34.58M
1.15%
50.11%
0.11%
Biotechnology
Healthcare
Link
Canada
Montreal